Again, my point is, anyone wanting to use the patents will want to own them. Your post does nothing to say that is incorrect.
You have already posted earlier that "Big Pharma" as you describe them,is the one with the resources to effectively use them, not Roquefort which you say is too small.
"Big Pharma" has already "looked elsewhere" to use your words. "Big Pharma" has said no, no, and no, when approached three times by Halasz, Wuurman and Walton. "Big Pharma" was already then aware of RNA technology.
You are suggesting that the Midkine patent setup is complicated. So what? What I am saying, again, is, if anybody wants to use it/them, they will want to own it/them. If not being able to do that because it is too hard, then I say they will ,again, "look elsewhere" to use your words.
- Forums
- ASX - By Stock
- AN1
- AFR Exclusive
AFR Exclusive, page-51
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
TON
TRITON MINERALS LTD
Adrian Costello, Executive Director
Adrian Costello
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online